Cargando…
Genotype–phenotype correlations in CPT1A deficiency detected by newborn screening in Pacific populations
Carnitine palmitoyltransferase 1A (CPT1A) deficiency is a long chain fatty acid oxidation disorder, typically presenting with hypoketotic hypoglycaemia and liver dysfunction during fasting and intercurrent illness. Classical CPT1A deficiency is a rare disease, although a milder ‘Arctic variant'...
Autores principales: | Bernhardt, Isaac, Glamuzina, Emma, Dowsett, Leah K., Webster, Dianne, Knoll, Detlef, Carpenter, Kevin, Bennett, Michael J., Maeda, Michelle, Wilson, Callum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259392/ https://www.ncbi.nlm.nih.gov/pubmed/35822099 http://dx.doi.org/10.1002/jmd2.12271 |
Ejemplares similares
-
The risk of classical galactosaemia in newborns with borderline galactose metabolites on newborn screening
por: Bernhardt, Isaac, et al.
Publicado: (2022) -
Utility of Genetic Testing for Confirmation of Abnormal Newborn Screening in Disorders of Long-Chain Fatty Acids: A Missed Case of Carnitine Palmitoyltransferase 1A (CPT1A) Deficiency
por: Dowsett, Leah, et al.
Publicado: (2017) -
Introducing Newborn Screening for Severe Combined Immunodeficiency—The New Zealand Experience
por: Heather, Natasha, et al.
Publicado: (2022) -
Introduction of a Protocol for Structured Follow-Up and Texting of Inadequate and Borderline-Positive Newborn Metabolic Screening Results
por: Heather, Natasha, et al.
Publicado: (2022) -
Detection of Early Onset Carnitine Palmitoyltransferase II Deficiency by Newborn Screening: Should CPT II Deficiency Be a Primary Disease Target?
por: Mador-House, Rachel, et al.
Publicado: (2021)